MEURX | VIHAX | MEURX / VIHAX | |
Total Expense Ratio | 0.95 | 0.17 | 559% |
Annual Report Gross Expense Ratio | 0.99 | 0.17 | 582% |
Fund Existence | 29 years | 10 years | - |
Gain YTD | 32.281 | 25.865 | 125% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 100000 | 3000 | 3,333% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 1.2B | 13.4B | 9% |
Annual Yield % from dividends | 2.30 | 3.95 | 58% |
Returns for 1 year | 24.86 | 18.56 | 134% |
Returns for 3 years | 75.26 | 63.45 | 119% |
Returns for 5 years | 106.54 | 69.66 | 153% |
Returns for 10 years | 75.63 | N/A | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
QTOP | 31.31 | 0.22 | +0.71% |
iShares Nasdaq Top 30 Stocks ETF | |||
EQWL | 114.93 | 0.80 | +0.70% |
Invesco S&P 100 Equal Weight ETF | |||
LABD | 32.34 | 0.16 | +0.50% |
Direxion Daily S&P Biotech Bear 3X ETF | |||
BSJT | 21.54 | 0.04 | +0.19% |
Invesco BulletShares 2029 HY Corp Bd ETF | |||
ANEW | 51.26 | N/A | N/A |
ProShares MSCI Trnsfmtnl Chngs ETF |